Overview
Pierluigi Porcu is an Oncologist in Philadelphia, Pennsylvania. Dr. Porcu is highly rated in 25 conditions, according to our data. His top areas of expertise are T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Bone Marrow Transplant, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 155 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
Locations
1101 Chestnut St Fl 14, Philadelphia, PA 19107
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
University Of Pennsylvania
Jakub Svoboda is an Oncologist in Philadelphia, Pennsylvania. Dr. Svoboda is highly rated in 27 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Abramson Cancer Center Perelman 2nd Floor West
Corey Langer is an Oncologist in Philadelphia, Pennsylvania. Dr. Langer is highly rated in 14 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Mesothelioma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Langer is currently accepting new patients.
Abramson Cancer Center Perelman 2nd Floor West
Charu Aggarwal is an Oncologist in Philadelphia, Pennsylvania. Dr. Aggarwal is highly rated in 18 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Aggarwal is currently accepting new patients.
Frequently Asked Questions about Dr. Pierluigi Porcu
How do I make an appointment with Dr. Pierluigi Porcu?
You can book an appointment with Dr. Pierluigi Porcu by calling their office at 215-955-8874. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Pierluigi Porcu a top-rated expert for T-Cell Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Pierluigi Porcu is classified as an Elite expert for T-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Pierluigi Porcu specialize in?
While Dr. Pierluigi Porcu is a Oncology, they have specific expertise in T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Mycosis Fungoides. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Pierluigi Porcu participate in research or clinical trials?
Yes. Dr. Pierluigi Porcu has published 155 articles and abstracts on conditions like T-Cell Lymphoma. You can view a list of Dr. Pierluigi Porcu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Pierluigi Porcu accept my insurance?
Dr. Pierluigi Porcu accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 215-955-8874 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cutaneous T-Cell Lymphoma (CTCL)
- Mycosis FungoidesDr. Porcu isElite. Learn about Mycosis Fungoides.
- Non-Hodgkin LymphomaDr. Porcu isElite. Learn about Non-Hodgkin Lymphoma.
- Peripheral T-Cell Lymphoma
- Sezary SyndromeDr. Porcu isElite. Learn about Sezary Syndrome.
- T-Cell LymphomaDr. Porcu isElite. Learn about T-Cell Lymphoma.
- Distinguished
- Adult T-Cell LeukemiaDr. Porcu isDistinguished. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell LymphomaDr. Porcu isDistinguished. Learn about Anaplastic Large Cell Lymphoma.
- B-Cell LymphomaDr. Porcu isDistinguished. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Porcu isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Lymphomatoid PapulosisDr. Porcu isDistinguished. Learn about Lymphomatoid Papulosis.
- Advanced
- Angioimmunoblastic T-cell Lymphoma
- Bone Marrow TransplantDr. Porcu isAdvanced. Learn about Bone Marrow Transplant.
- Chronic B-Cell Leukemia (CBCL)Dr. Porcu isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Exfoliative DermatitisDr. Porcu isAdvanced. Learn about Exfoliative Dermatitis.
- Follicular LymphomaDr. Porcu isAdvanced. Learn about Follicular Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Porcu isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Porcu isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Porcu isExperienced. Learn about Acute Myelomonocytic Leukemia.
- AgranulocytosisDr. Porcu isExperienced. Learn about Agranulocytosis.